CG MedTech Co

CG MedTech Co Days Payable Outstanding

The Days Payable Outstanding (DPO) of CG MedTech Co (056090.KQ) as of Nov 19, 2026 is 19.89. In the previous year, Days Payable Outstanding (DPO) was 48.45 — a change of -58.96% (lower).

Days Payable Outstanding

19.89

YoY

-58.96%

Last updated:

Days Payable Outstanding (DPO) of CG MedTech Co is 2025 19.89 . Days Payable Outstanding (DPO) of CG MedTech Co was 2024 48.45 . It decreases by -58.96% lower compared to the previous year.

The CG MedTech Co Days Payable Outstanding history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Days Payable Outstanding
Date
Days Payable Outstanding
Jan 1, 2017
57.64 KRW
Jan 1, 2018
21.79 KRW
Jan 1, 2019
25.28 KRW
Jan 1, 2020
20.63 KRW
Jan 1, 2022
20.15 KRW
Jan 1, 2023
32.41 KRW
Jan 1, 2024
48.45 KRW
Jan 1, 2025
19.89 KRW
The CG MedTech Co Days Payable Outstanding history
YEARDays Payable OutstandingYoY
19.89-58.96%
48.45+49.49%
32.41+60.86%
20.15-2.32%
20.63-18.40%
25.28+16.02%
21.79-62.20%
57.64+56.62%
36.80-49.14%
72.35+2.28%
70.74—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

CG MedTech Co Stock analysis

What does CG MedTech Co do? CG MedTech Co Ltd generates revenue through two primary business segments. The Medical Device Business segment produces and sells spinal fixation devices, micro-invasive medical devices for back pain treatment, fracture treatment devices, and bioabsorbable alloy implants. These products are sold to healthcare providers and hospitals within the orthopaedic surgical market. The Electric Energy Business segment manufactures and markets electricity meters and integrated calorimeters, targeting utility companies and energy management sectors. Both segments operate under the company's established brand presence in their respective industries. The company's revenue streams are derived from direct sales to end-users in the medical and energy sectors. Orthopaedic surgical implants and devices are purchased by hospitals and clinics specializing in orthopaedic care, while electricity meters and calorimeters are bought by utility providers for infrastructure deployment. The firm's product portfolio is designed to meet specific technical requirements within these specialized markets. CG MedTech Co Ltd's business model focuses on manufacturing high-precision medical devices and energy measurement equipment. The Medical Device Business segment serves the healthcare industry with products for spinal and fracture treatments, while the Electric Energy Business segment supports energy management through metering solutions. This dual-segment approach allows the company to serve two distinct but complementary industrial sectors. CG MedTech Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about CG MedTech Co stock

Days Payable Outstanding (DPO) of CG MedTech Co is 19.89 in 2025.

Days Payable Outstanding (DPO) of CG MedTech Co changed from 48.45 to 19.89, representing a -58.96% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Days Payable Outstanding (DPO) CG MedTech Co since 2006 – with annual values, charts, and detailed analysis.

DPO measures the average number of days a company takes to pay its suppliers. Higher DPO can improve cash flow but may strain supplier relationships.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Days Payable Outstanding (DPO)'s CG MedTech Co with sector peers and the industry average to assess whether it is attractive.

To evaluate Days Payable Outstanding (DPO)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Days Payable Outstanding (DPO).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — CG MedTech Co

All Key Metrics — CG MedTech Co